Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PPD Appoints CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

PPD Appoints CEO

Pfizer vet to take reins at CRO

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

David Simmons has been appointed chairman and chief executive officer of PPD. Mr. Simmons joins the company from Pfizer, where he served as president and general manager of the emerging markets and established products business units. Mr. Simmons will be based in PPD’s headquarters in Wilmington, NC.
 
“We are pleased to welcome David to PPD,” said Stephen H. Wise, managing director of The Carlyle Group and PPD board member. “David is a proven leader whose deep industry knowledge and vision will enable PPD to further its partnerships with pharmaceutical and biotech companies around the globe.”
 
Mr. Simmons spent 15 years with Pfizer in several senior roles. In his most recent position, Mr. Simmons was responsible for the emerging markets and established products business units, which represented approximately $18.5 billion of Pfizer’s annual revenue. Additionally, he was responsible for the biosimilar development program. Prior to this role, Mr. Simmons held various positions of increasing responsibility in information technology and pharmaceutical operations, including roles in several countries around the world.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics